Fox Chase Cancer Center
Quick facts
Marketed products
- targeted therapy · Oncology
Targeted therapy refers to drugs designed to attack specific molecular features of cancer cells, such as mutations or overexpressed proteins, while sparing normal cells. - Use of buprenorphine with FAO > 30 OME · Pain Management / Opioid Use Disorder
Buprenorphine is a partial mu-opioid receptor agonist that provides analgesia and is used in opioid-dependent patients, with dose adjustment required when combined with other opioids exceeding 30 oral morphine equivalents.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: